ADA Presidents Select Abstract: Potential Gains in Life Expectancy (LE) Associated with Achieving Treatment Goals in People with Type 2 Diabetes (T2D) in the U.S

被引：3
|
作者：
Kianmehr, Hamed
Zhang, Ping
Pavkov, Meda E.
Bullard, Kai M.
Fonseca, Vivian
Shi, Lizheng
Shao, Hui
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-139-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
139-OR
引用
收藏
页数：4
相关论文
共 34 条
  • [1] Potential Gains in Life Expectancy Associated With Achieving Treatment Goals in US Adults With Type 2 Diabetes
    Kianmehr, Hamed
    Zhang, Ping
    Luo, Jing
    Guo, Jingchuan
    Pavkov, Meda E.
    Bullard, Kai McKeever
    Gregg, Edward W.
    Ospina, Naykky Singh
    Fonseca, Vivian
    Shi, Lizheng
    Shao, Hui
    [J]. JAMA NETWORK OPEN, 2022, 5 (04) : E227705
  • [2] ADA Presidents' Select Abstract: Structural Lesions on Kidney Biopsy in Youth-Onset Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D)
    Nair, Viji
    Naik, Abhijit
    Alakwaa, Fadhl
    Schaub, Jennifer A.
    Vigers, Timothy B.
    Bitzer, Markus
    Pyle, Laura
    Brosius, Frank C., III
    Ladd, Patricia E.
    Shah, Viral
    Tommerdahl, Kalie L.
    Sharma, Kumar
    De Boer, Ian
    Saulnier, Pierre-Jean
    Looker, Helen C.
    Nelson, Robert G.
    Hodgin, Jeffrey B.
    Bjornstad, Petter
    [J]. DIABETES, 2023, 72
  • [3] Predictive Factors for Achieving Glycemic Control in People with Type 2 Diabetes (T2D) in Real Clinical Practice
    Chaudhury, Tirthankar
    Al Mansari, Abdulqawi
    Obeid, Youssef
    Islam, Najamul
    Fariduddin, Mohammed
    Hassoun, Ahmed
    Djaballah, Khier
    Malek, Mojtaba
    [J]. DIABETES, 2017, 66 : A615 - A616
  • [4] ADA Presidents' Select Abstract: The Balance of Vascular Tone in the Afferent (RA) and Efferent (RE) Arterioles Associates with Diabetic Kidney Lesions and Predicts Progression to End Stage Kidney Disease (ESKD) in Type 2 Diabetes (T2D)
    Saulnier, Pierre-Jean
    Looker, Helen C.
    Mauer, Michael
    Nelson, Robert G.
    Bjornstad, Petter
    [J]. DIABETES, 2020, 69
  • [5] Pediatric Diabetes Providers Are Poorly Adherent to the ADA Treatment Guidelines for New-Onset Type 2 Diabetes (T2D)
    Said, Jeries H.
    Wolfgram, Peter
    Cabrera, Susanne M.
    [J]. DIABETES, 2022, 71
  • [6] ADA Presidents' Select Abstract: Cardiovascular Autonomic Neuropathy Is Associated with Rapid Kidney Function Decline in Type 2 Diabetes: Findings from the ACCORD Trial
    Tang, Yaling
    Junior, Carlos Bueno
    Shah, Hetal
    Ang, Lynn
    Pop-Busui, Rodica
    Doria, Alessandro
    [J]. DIABETES, 2021, 70
  • [7] Type 2 Diabetes (T2D) Treatment for Canada's First-Nations Population
    Winterstein, Jeffrey
    Mcgillis, Susan
    [J]. DIABETES, 2017, 66 : A461 - A461
  • [8] ADA Presidents' Select Abstract: Effects of Tirzepatide vs. Insulin Glargine 100 U/mL on Kidney Outcomes in Participants with Type 2 Diabetes in SURPASS-4
    Heerspink, Hiddo L.
    Sattar, Naveed
    Pavo, Imre
    Haupt, Axel
    Duffin, Kevin L.
    Yang, Zhengyu
    Wiese, Russell
    Tuttle, Katherine R.
    Cherney, David
    [J]. DIABETES, 2022, 71
  • [9] Real-Life Effectiveness of iGlarLixi (Insulin Glargine 100 U/ml and Lixisenatide) in People with Type 2 Diabetes (T2D) according to Baseline BMI
    Kis, Janos T.
    Seufert, Jochen
    Haluzik, Martin
    Vera, Carine
    Tournay, Mathilde
    Bonnemaire, Mireille
    Freemantle, Nick
    Guja, Cristian
    [J]. DIABETES, 2024, 73
  • [10] The cost-effectiveness of the early insulin use treatment pathway in the ADA/EASD joint consensus algorithm for the treatment of type 2 diabetes (T2D)
    Willis, Michael
    Asseburg, Christian
    Neslu-San, Cheryl
    Persson, Ulf
    [J]. DIABETES, 2008, 57 : A98 - A98
1234